David Pyrce Appointed as New CEO of Cognigenics, Inc., to Drive Innovation in RNA-Based Therapies
Key Highlights David Pyrce, a veteran with over 30 years in the biotech and pharma industry, is appointed…
Browsing Tag
Wells Fargo/Van Kasper Securities
1 post